Podpůrná terapie v hematologii

A no-prophylaxis platelet-transfusion strategy for hematologic cancers

Diagnosis and treatment of mucormycosis in patiens with hematological malignancies, guidelines form the 3rd European conference on infections in leukemia (ECIL 3)

Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American society of clinical oncology clinical practice guideline

Management of cytomegalovirus infection in haemopoietic stem cell transplantation

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic Cell Transplantation

Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)

Role of granulocyte/neutrophil transfusions for haematology/oncology patients in the modern era

Therapeutic platelet transusion versus routine prophylatic transfusion in patiens with haematological malignancies: an open label, multicentre, randomised study

Association Between Transusion With Human Herpesvirus Antipody - positive Blood and Subsequent Mortality

ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic pacients and hematopoietic SCT recipients

How I treat hematologic emergencies in adults with acute leukemia

Voriconazole versus itraconazole for antifungal prophylaxis folowing allogeneic haematopoetic stem-cell transplantation

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America

Review of guidelines the prevention and treatment of infection in patients with an absent or dysfunctional spleen: Prepared on behalf of the British Committee for Standards in Haematology by a Working Party of the Heamatolo-Oncology Task Force

Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbopoetin Alfa for Patients With Chemotherapy-Associated Anemia

American society of clinical oncology/American society of hematology clinical guideline update on the use of epoetin and darbepoetin in adult patients with cancer

Factors associated with mortality in transplant patients with invasive aspergillosis

Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis

Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3 - 2009 update

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

Randomized placebo-controlled trial of granulocyte colony stimulating factor (G-CSF) as supportive care after induction chemotherapy in adult patients with acute myeloid leukaemia: a study of the United Kingdom Medical research council Adult leukaemia working party

American society of clinical oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious diseases society of America

Empirical vs Preemptive Antifungal Therapy for High-Risk, Fibrile, Neutropenic Patiens : A Randomized, Controlled Trial

An EORTC phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients

Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious diseases working party of the German society for haemathology and oncology.

A prospective randomized controlled trial comparing PCR-based empirical treatment with liposomal amphotericin B in patients after allo-SCT

Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial

Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases

A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia

American Society of Clinical Oncology guideline for antiemetics in oncology: Update 2006.

Antiemesis, version I. 2008. National comprehensive cancer network clinical practice guidelines in oncology.

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: Systematic review and meta-analysis.

Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update.

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities

Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

Consensus conference on the management of tumor lysis syndrome

Randomized Comparison of Cooked and Noncooked Diets in Patiens Undergoing Remission Induction Therapy for Acute Myeloid Leukemia

Guidelines from the First European Conference on Infections in Leukaemia (ECIL 1) Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients

Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients.

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia